SLABÝ, Ondřej, Martina RÉDOVÁ, Alexandr POPRACH, Jana NEKVINDOVÁ, Robert ILIEV, Lenka RADOVÁ, Radek LAKOMÝ, Marek SVOBODA and Rostislav VYZULA. Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients. Genes Chromosomes & Cancer. MALDEN, USA: WILEY-BLACKWELL, 2012, vol. 51, No 7, p. 707-716. ISSN 1045-2257. Available from: https://dx.doi.org/10.1002/gcc.21957.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients
Authors SLABÝ, Ondřej (203 Czech Republic, guarantor, belonging to the institution), Martina RÉDOVÁ (203 Czech Republic, belonging to the institution), Alexandr POPRACH (203 Czech Republic), Jana NEKVINDOVÁ (203 Czech Republic), Robert ILIEV (203 Czech Republic), Lenka RADOVÁ (203 Czech Republic), Radek LAKOMÝ (203 Czech Republic), Marek SVOBODA (203 Czech Republic, belonging to the institution) and Rostislav VYZULA (203 Czech Republic).
Edition Genes Chromosomes & Cancer, MALDEN, USA, WILEY-BLACKWELL, 2012, 1045-2257.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.546
RIV identification code RIV/00216224:14740/12:00060119
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1002/gcc.21957
UT WoS 000303762500008
Keywords in English microRNA; renal cell carcinoma; relaps; nephrectomy
Tags ok, rivok
Tags International impact, Reviewed
Changed by Changed by: Olga Křížová, učo 56639. Changed: 23/4/2013 07:17.
Abstract
Renal cell carcinoma (RCC) is the most common neoplasm of adult kidney. One of the important unmet medical needs in RCC is prognostic biomarker enabling identification of patients at high risk of relapse after nephrectomy. MicroRNAs (miRNAs) constitute a robust regulatory network with posttranscriptional regulatory efficiency for almost one-half of human coding genes, including oncogenes and tumor suppressors.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
PrintDisplayed: 18/9/2024 10:30